Birth of healthy children after preimplantation diagnosis of beta-thalassemia by whole-genome amplification.
Preimplantation genetic diagnosis (PGD) offers couples at risk for transmitting an inherited disorder the possibility to avoid the need to terminate affected pregnancies. PGD for monogenic diseases is most commonly accomplished by blastomere biopsy from cleavage-stage embryos, followed by PCR-based DNA analysis. However, the molecular heterogeneity of many monogenic diseases requires a diagnostic strategy capable of detecting a range of mutations and compound genotypes. With the above considerations, we developed an accurate and reliable strategy for analysis of beta-globin gene mutations, applicable for PGD for the wide spectrum of beta-thalassemia major mutations in the Chinese population. The strategy involves primer-extension preamplification (PEP), followed by nested PCR and reverse dot blot (RDB) for mutation detection since it facilitates simultaneous analysis of more than one mutation in a single cell. This report describes the application of the strategy in two clinical IVF/PGD cycles at risk for transmitting beta-thalassemia major, which resulted in the first thalassemia-free children born after PGD in China.
Jiao
Zexu
Z
Reproductive Medical Center, First Affiliated Hospital of Sun Yet-Sen University, Guangzhou, China. zexujiao@yahoo.com.cn
Zhou
Canquan
C
Li
Jie
J
Shu
Yimin
Y
Liang
Xiaoyan
X
Zhang
Mingfang
M
Zhuang
Guanglun
G
D000328:Adult; D001706:Biopsy; D046508:Culture Techniques; D004624:Embryo Transfer; D004622:Embryo, Mammalian; D005260:Female; D005914:Globins / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D008297:Male; D009154:Mutation; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011256:Pregnancy Outcome; D019836:Preimplantation Diagnosis; D020554:Sperm Injections, Intracytoplasmic; D017086:beta-Thalassemia / Q000175:diagnosis* / Q000235:genetics*
D005914:Globins